mRNA levels measured by qRT-PCR from the uterus and endometriosis vesicles.

The study examined whether antagonizing corticotropin-releasing hormone receptor 1 (CRHR1) with the antagonist antalarmin alters uterine and lesion-related gene expression in an endometriosis rat model. Using qRT-PCR, the authors measured mRNA levels of CRHR1, CRHR2, and the glucocorticoid receptor (GR), normalizing expression to the uterus of sham rats, with n=9 per vehicle and antalarmin group. They reported significant differences (p<0.05) indicated by comparing antalarmin-treated tissue to sham uterus, although the figure text does not specify directionality for each gene. This paper is centrally about endometriosis — it focuses on reducing endometriosis progression via CRHR1 antagonism and includes qRT-PCR of uterine and endometriosis vesicle gene expression.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works